Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
June 17, 2026
[The Freiburg concept of the "Neurological Emergency Receiving Team (NERT)" : Concept for structuring of time-critical courses of action for patients with a predominant disability problem with an interdisciplinary and interprofessional emergency team in the nontraumatological resuscitation room]
J Brich, M Hieber, S Petrik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 24, 2010
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
P H Lalive, M G Häusler, H Maurey, et al.
European Journal of Neurology
|
January 20, 2019
Immunophenotyping of cerebrospinal fluid cells in ischaemic stroke
A Schulte-Mecklenbeck, I Kleffner, C Beuker, et al.
Neurology
|
March 24, 2004
Rasmussen encephalitis with active inflammation and delayed seizures onset
I Korn-Lubetzki, C G Bien, J Bauer, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 22, 2015
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
P S Rommer, T Dörner, K Freivogel, et al.
Neurology
|
February 4, 2012
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control
N Schwab, J C Ulzheimer, R J Fox, et al.
Multiple Sclerosis and Related Disorders
|
February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study
G Saposnik, S Andhavarapu, Ó Fernández, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A Harrer, H Tumani, S Niendorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 11, 2014
Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series
M Dogan Onugoren, D Deuretzbacher, C A Haensch, et al.
Der Nervenarzt
|
August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]
P Kolber, F Luessi, S G Meuth, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|
June 17, 2026
[The Freiburg concept of the "Neurological Emergency Receiving Team (NERT)" : Concept for structuring of time-critical courses of action for patients with a predominant disability problem with an interdisciplinary and interprofessional emergency team in the nontraumatological resuscitation room]
J Brich, M Hieber, S Petrik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 24, 2010
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children
P H Lalive, M G Häusler, H Maurey, et al.
European Journal of Neurology
|
January 20, 2019
Immunophenotyping of cerebrospinal fluid cells in ischaemic stroke
A Schulte-Mecklenbeck, I Kleffner, C Beuker, et al.
Neurology
|
March 24, 2004
Rasmussen encephalitis with active inflammation and delayed seizures onset
I Korn-Lubetzki, C G Bien, J Bauer, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 22, 2015
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
P S Rommer, T Dörner, K Freivogel, et al.
Neurology
|
February 4, 2012
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control
N Schwab, J C Ulzheimer, R J Fox, et al.
Multiple Sclerosis and Related Disorders
|
February 26, 2022
Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study
G Saposnik, S Andhavarapu, Ó Fernández, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 25, 2012
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A Harrer, H Tumani, S Niendorf, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 11, 2014
Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series
M Dogan Onugoren, D Deuretzbacher, C A Haensch, et al.
Der Nervenarzt
|
August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]
P Kolber, F Luessi, S G Meuth, et al.
Page
of 8